Talk about niche target-marketing to hypochondriacs and Teh Coof-obsessesed.
UPI: FDA authorizes first at-home test to detect both flu and COVID-19.
The Lucira test will be sold over-the-counter and it can detect both Influenza A and Influenza B, as well as the SARS-CoV-2 virus - the virus that causes COVID-19, FDA officials announced Friday in a news release.
The announcement marks a breakthrough as the first at-home test for flu, the Washington Post reported. Testing for the flu previously required a visit to a doctor's office or urgent care clinics.
Will a majority of people make a mad-dash, rushing to test themselves the moment they sneeze or have a runny nose? Probably, based on the number of past, current and "I plan to take all future Coof Boosters" Jab Addicts and Mask-Karens.
Lucira. The FDA approved an at-home test from a company whose stock closed on Friday at .14 cents, whose all-time high of $37/share was two years ago and their 52W high is $5.67? Oh, yeah - full faith and trust, BAYBEE!
It might be a worth a look as a short-term buy-hold-sell when or if it hits "dollars." (This is not presented or intended in any way as financial or investment advice.*)

If I felt energetic, I'd search who the big buyers and investors of Lucira stock are the past 30-90 days. I wonder if Paul "The Hammer" Pelosi, Sr. or other spouses of politicians sank some $$$$$ into this Pharma Company?
With a 52W low of .04 cents, Lucira badly needed a Booster product. I wonder how many palms at the FDA and TPTB were greased? It'd be great if this product failed.
* DISCLAIMER: Lucira stock assessment is purely speculative. It is NOT financial advice. Author assumes no risk, responsibility and/or liability for any financial
losses. Immediately seek trained health
professionals if you have the slightest inclination rolling dice with your
financial risk based on anything written anywhere on this blog.